retatrutide type 2 diabetes phase 2 trial is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 The Effect of Retatrutide on
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and or Obesity ScienceDirect Phase 2 trial results demonstrate benefits of retatrutide in obesity, type 2 diabetes, NASH ADA Meeting News A New Obesity Drug Delivered Surgery Level Weight Loss in Clinical Trials Discover Magazine ESC 2024: Retatrutide improves lipid and cardiovascular risk profile in Phase II trial Clinical Trials Arena In the Phase 3 TRANSCEND T2D 1 trial, patients with type 2 diabetes experienced:, Up to 2% A1C reduction, 90% achieved an A1C <7%, 85% achieved an A1C <6.5%, 46% achieved normal glycemia retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, an experimental weight loss drug
Store: clickpoint.com.au · Domain: clickpoint.com.au























